glyceraldehyde has been researched along with HIV in 1 studies
Glyceraldehyde: An aldotriose containing the propionaldehyde structure with hydroxy groups at the 2- and 3-positions. It is involved in the formation of ADVANCED GLYCOSYLATION END PRODUCTS.
glyceraldehyde : An aldotriose comprising propanal having hydroxy groups at the 2- and 3-positions. It plays role in the formation of advanced glycation end-products (AGEs), a deleterious accompaniment to ageing.
aldose : Aldehydic parent sugars (polyhydroxy aldehydes H[CH(OH)]nC(=O)H, n >= 2) and their intramolecular hemiacetals.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine), a nucleoside reverse transcriptase inhibitor with extremely potent anti-HIV activity, was concisely synthesized from (R)-glyceraldehyde acetonide in an 18% overall yield by a 12-step sequence involving highly diastereoselective ethynylation of an α-alkoxy ketone intermediate." | 3.78 | Concise synthesis of the anti-HIV nucleoside EFdA. ( Kageyama, M; Kuwahara, S; Miyagi, T; Nagasawa, T; Ohrui, H; Yoshida, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kageyama, M | 1 |
| Miyagi, T | 1 |
| Yoshida, M | 1 |
| Nagasawa, T | 1 |
| Ohrui, H | 1 |
| Kuwahara, S | 1 |
1 other study available for glyceraldehyde and HIV
| Article | Year |
|---|---|
Concise synthesis of the anti-HIV nucleoside EFdA.
Topics: Anti-HIV Agents; Deoxyadenosines; Glyceraldehyde; HIV; HIV Reverse Transcriptase; Humans; Magnetic R | 2012 |